[ad_1]
IDEXX Laboratories is a global leader in pet healthcare innovation and recently, the company announced a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs. Dubbed IDEXX Cancer Dx™, this innovation is important as studies show that 20 million dogs are at higher risk for cancer in North America, with one in four dogs expected to be diagnosed in their lifetime.
IDEXX Cancer Dx™ is essentially “an affordable and accessible blood test that can be added to panels for sick pets and integrated into annual wellness screenings for as low as $15.” The diagnostic panel is high in sensitivity and accuracy while the design of the service is streamlined to seamlessly fit existing veterinary workflows. The results come with IDEXX Medical Consultants — from board-certified oncologists to internists.
Image Credit: IDEXX Laboratories
[ad_2]
Source link
